CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual)
- PMID: 38118006
- PMCID: PMC10732551
- DOI: 10.1093/cid/ciad568
CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual)
Abstract
In response to the global threat of antimicrobial resistance (AMR), the Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) project worked with microbiology laboratories, pharmacies, and local governments in South Asia and Southeast Asia to expand the volume of historical and current data available on AMR and antimicrobial use and to identify gaps in data and areas for quality improvement. When the CAPTURA project completed its country-level engagement in the first half of 2022, the consortium brought together local, regional, and global AMR stakeholders for a virtual regional workshop to review data outputs from the project and share strategies to inform national and regional efforts to combat AMR. This paper summarizes the main topics presented in the workshop held from 28 to 30 June 2022. As such, it highlights lessons learned from the project and strategies to fight AMR. Although CAPTURA has been invaluable to countries and information from the project is already being used, barriers concerning data quality and sharing remain. Regional-level initiatives should continue to build on the momentum gained from the CAPTURA project in supporting national-level surveillance and data quality improvements to inform critical decisions around planning, policies, and clinical care. Project findings have highlighted that issues with antimicrobial resistance and use are wide ranging across countries. Going forward, building on the current foundations and tailoring approaches to meet local needs and capacities will be fundamental in combatting AMR.
Keywords: Antimicrobial Resistance (AMR); Fleming Fund Regional Grant; Regional Workshop; South Asia; Southeast Asia.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. T. L. reports funding from Mott McDonald Ltd and the Fleming Fund. P. O. reports that part of their salary is provided by The Fleming Fund. E. E. reports being a consultant with the International Vaccine Institute since April 2021 and staff and consulting funds from the WHO WPRO, ABD, FHI, and UNICEF. J. S. reports a subcontract for salary support and travel from the International Vaccine Institute. B. D. reports compensation from the Public Health Surveillance Group. W. M. reports a subgrant for the CAPTURA project from the International Vaccine Institute and is a grantee of UKaid. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
References
-
- O’Neill J. The review on antimicrobial resistance. Tackling drug-resistant infections globally: final report and recommendations: Government of the United Kingdom2016.
-
- Fleming Fund . Available at:https://www.flemingfund.org/. Accessed 30 April 2023.
-
- The CAPTURA Project. Available at: https://captura.ivi.int/. Accessed 10 April 2023.
-
- Holm M, MacWright WR, Poudyal N, et al. Capturing data on Antimicrobial resistance Patterns and Trends in Use in Regions of Asia (CAPTURA). Clin Infect Dis 2023; 77(Suppl 7):S500–6. - PubMed
-
- Joh HS, Yeats C, Shaw A, et al. Methodological approach to identify and expand the volume of antimicrobial resistance (AMR) data in the human health sector in low- and middle-income countries in Asia: implications for local and regional AMR surveillance systems strengthening. Clin Infect Dis 2023; 77(Suppl 7):S507–18. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
